{"gene":"ADORA2A","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1990,"finding":"RDC8 (ADORA2A) encodes an adenosine A2 receptor that constitutively activates adenylyl cyclase and the cAMP cascade; expression in COS7 cells conferred adenosine A2 binding characteristics, and this constitutive activity was inhibited by adenosine deaminase and adenosine A2 receptor antagonists.","method":"Heterologous expression in Y1 adrenal cells, dog thyrocytes, Xenopus oocytes, and COS7 cells; radioligand binding assay; adenylyl cyclase activity assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — reconstituted receptor activity in multiple cell systems with pharmacological validation and binding assay","pmids":["2125216"],"is_preprint":false},{"year":1991,"finding":"ADORA2A (RDC8) is selectively expressed by enkephalinergic medium spiny neurons in the striatum (caudate-putamen), but not by substance P-containing or cholinergic neurons.","method":"In situ hybridization histochemistry combined with neuronal subtype markers in rat brain","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — direct localization with cellular specificity established by co-detection of multiple neuronal markers","pmids":["1713612"],"is_preprint":false},{"year":1996,"finding":"The human ADORA2A gene is organized into two exons interrupted by an ~6.4 kb intron and is chromosomally localized to 22q11.2 by fluorescent in situ hybridization and PCR analysis of hybrid cell panels.","method":"Genomic cloning, sequence analysis, FISH, PCR of human-hamster hybrid cell panels","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal localization by two independent methods (FISH and hybrid cell panel PCR)","pmids":["8670304"],"is_preprint":false},{"year":2013,"finding":"The ADORA2A AA diplotype (haplotype A of rs2298383/rs5751876/rs35320474/rs4822492) is associated with higher ADORA2A mRNA and protein expression and increased cAMP production in lymphoblasts in response to adenosine, linking a genetic variant to altered intracellular adenosine/cAMP signaling.","method":"SNP genotyping, mRNA expression (qPCR), protein expression (Western blot), cAMP production assay in lymphoblasts","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (mRNA, protein, functional cAMP assay) in a single study linking genotype to receptor function","pmids":["23535492"],"is_preprint":false},{"year":2019,"finding":"Endothelial cell-specific deletion of Adora2a protects mice from diet-induced insulin resistance-associated blood-brain barrier (BBB) breakdown, demonstrating that Adora2a signaling in vascular endothelial cells mediates tight junction erosion, vascular inflammation, and consequent deficits in hippocampal synaptic plasticity and cognition.","method":"Inducible endothelial-specific Adora2a knockout mice; BBB permeability assays (sodium fluorescein, Evans blue); transmission electron microscopy of tight junctions; acute pharmacological antagonism; hippocampal LTP recording; behavioral memory tasks","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific genetic knockout with multiple orthogonal readouts (permeability, ultrastructure, plasticity, behavior), replicated by pharmacological antagonism","pmids":["30886019"],"is_preprint":false},{"year":2023,"finding":"ADORA2A activation rewires proline metabolism through an ERK/MYC/PYCR cascade; increased proline synthesis promotes SIRT6/7-mediated deacetylation of H3K27, biasing transcription toward a neuroendocrine lineage profile. Genetic ablation of Adora2a in mouse models inhibits neuroendocrine prostate and lung cancer development.","method":"Genetically engineered mouse models (Adora2a KO); pharmacological ADORA2A blockade in vivo; transcriptomic and metabolic analyses; ChIP for H3K27ac; epistasis with ERK/MYC/PYCR pathway inhibitors","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1/2 — in vivo genetic KO with mechanistic pathway dissection (ERK/MYC/PYCR/SIRT6/7/H3K27ac) using multiple orthogonal methods","pmids":["38099497"],"is_preprint":false},{"year":2022,"finding":"JMJD3-mediated H3K27me3 demethylation upregulates ADORA2A expression, which in turn inhibits caspase-3 cleavage to suppress macrophage apoptosis in LPS-induced acute lung injury; C/EBPβ also enhances ADORA2A expression downstream of H3K27me3 demethylation.","method":"Chromatin immunoprecipitation; LPS-induced ALI mouse model and RAW264.7 cell model; TUNEL staining; flow cytometry apoptosis assay; Western blot; siRNA knockdown of JMJD3 and ADORA2A","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional KD with apoptosis readout in matched in vivo and in vitro systems","pmids":["36456564"],"is_preprint":false},{"year":2023,"finding":"Adenosine activates ADORA2A to promote phosphorylation of STAT3 and AKT, resulting in increased angiogenin (Ang)-dependent angiogenesis in placenta; ADORA2A expression is downregulated in IUGR placenta and adenosine supplementation improves IUGR outcomes in mice.","method":"In vitro angiogenesis assays; in vivo Matrigel plug assays; Western blot for pSTAT3 and pAKT; diet-induced IUGR mouse model; ADORA2A expression quantification","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo functional assays with signaling pathway validation (pSTAT3/pAKT) in multiple systems","pmids":["37051927"],"is_preprint":false},{"year":2023,"finding":"ADORA2A promotes colorectal carcinoma cell proliferation and inhibits apoptosis via the PI3K/AKT signaling pathway, modulating Bcl-2, Bax, cleaved caspase-3, and cleaved caspase-9 levels.","method":"siRNA knockdown and plasmid overexpression of ADORA2A in CRC cell lines; CCK-8, colony formation, wound healing, transwell assays; flow cytometry apoptosis; Western blot for PI3K/AKT and apoptosis proteins","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional manipulation (KD and OE) with consistent signaling and phenotypic readouts","pmids":["37945707"],"is_preprint":false},{"year":2020,"finding":"miR-497 and miR-195 directly target ADORA2A; promoter CpG island methylation silences the miR-497-195 cluster, leading to upregulation of ADORA2A which activates the cAMP/PKA signaling pathway and promotes osteogenic differentiation of posterior longitudinal ligament cells.","method":"Luciferase reporter assay (miRNA target validation); methylation analysis with demethylation reagent 5-aza-2'-deoxycytidine; overexpression and knockdown of miR-195/miR-497; cAMP/PKA pathway readout by Western blot; osteogenic factor expression","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — validated miRNA-target relationship with epigenetic mechanism and downstream signaling readout","pmids":["32432317"],"is_preprint":false},{"year":2025,"finding":"PARP1-mediated PARylation of POLG triggers its ubiquitination and downregulation, causing mitochondrial dysfunction and activating Adora2a/Rap1 signaling to induce VSMC ferroptosis and vascular calcification; Adora2a inhibition attenuates this process.","method":"VSMC knockout mouse models (Parp1flox/flox Tagln Cre+); AAV9-mediated POLG knockdown; RNA-sequencing; Western blot for PARylation and Adora2a/Rap1; functional calcification and ferroptosis assays","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and molecular dissection of PARP1-POLG-Adora2a pathway in matched in vivo and in vitro models","pmids":["40401372"],"is_preprint":false},{"year":2025,"finding":"AMP is converted to adenosine by ecto-5'-nucleotidase (CD73), and adenosine activates ADORA2A signaling to reduce DNA methylation at the hormone-sensitive lipase (HSL) promoter, thereby promoting HSL transcription and white adipose tissue lipolysis; ADORA2A knockout abolishes these metabolic benefits.","method":"ADORA2A knockout mice; ADORA2A re-expression rescue; DNA methylation analysis; HSL transcription assay; metabolic phenotyping in high-fat diet mice","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — KO plus rescue genetic strategy with epigenetic and transcriptional mechanistic readouts","pmids":["39976204"],"is_preprint":false},{"year":2022,"finding":"ADORA2A and DRD2 form heterodimers in human retinal pigment epithelial (RPE) cells, as demonstrated by immunofluorescence colocalization and co-immunoprecipitation; the adenosine receptor antagonist 7-methylxanthine inhibits ADORA2A expression and increases DRD2 and downstream pERK1/2 signaling.","method":"Immunofluorescence; co-immunoprecipitation; siRNA knockdown of DRD2; Western blot for ERK1/2 and pERK1/2; CCK-8 and flow cytometry for cell viability","journal":"Ophthalmic research","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-immunoprecipitation demonstrating ADORA2A-DRD2 heterodimer with functional downstream signaling validation","pmids":["35724635"],"is_preprint":false},{"year":2024,"finding":"Caffeine pretreatment reduces hippocampal Il1b expression and downregulates Adora2a expression in mice; LPS reverses caffeine-induced Adora2a downregulation. Bioinformatics identified MAPK3, ARRB2, and ADORA2B as network connectors to ADORA2A's extended signaling network.","method":"In vivo mouse model (caffeine + LPS); qPCR for Adora2a and cytokines; DNA methyltransferase expression analysis; bioinformatics network analysis","journal":"Brain research","confidence":"Low","confidence_rationale":"Tier 3 — in vivo expression data with pharmacological perturbation but limited mechanistic dissection","pmids":["38494098"],"is_preprint":false},{"year":2024,"finding":"Brain-specific RagA overexpression elevates ADORA2A expression and phospho-p70S6K in the prefrontal cortex; pharmacological inhibition of ADORA2A with istradefylline attenuates depressive-like behaviors in RagA transgenic mice, placing ADORA2A downstream of RagA/p70S6K in a depression-related signaling pathway.","method":"RagA transgenic mice; RNA-seq of prefrontal cortex; Western blot for ADORA2A and p70S6K; behavioral testing with ADORA2A antagonist; metabolomics and proteomics","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic model with transcriptomic/proteomic profiling plus pharmacological rescue establishing pathway placement","pmids":["39373701"],"is_preprint":false},{"year":2024,"finding":"Retina-specific AdoRA2a knockout (AdoRA2a-CKO) mice show attenuated form deprivation myopia progression; AdoRA2a and Drd2 are colocalized in the retina, and the selective AdoRA2a antagonist KW6002 fails to inhibit myopia in Drd2-CKO mice, demonstrating that retinal AdoRA2a promotes myopia progression through an AdoRA2a-Drd2 interaction mechanism.","method":"Retina-specific CKO mice; pharmacological AdoRA2a antagonism (KW6002); Drd2-CKO epistasis experiment; immunolocalization of AdoRA2a and Drd2; refractive error measurement","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO plus genetic epistasis (Drd2 KO) establishing pathway placement with pharmacological corroboration","pmids":["41533917"],"is_preprint":false},{"year":2024,"finding":"A MiniPromoter derived from ADORA2A regulatory regions (Ple389) drives selective gene expression in D2-receptor-positive medium spiny neurons in the striatum of mice and non-human primates when delivered via rAAV, validated by co-localization with dopamine D2 receptor and DARPP32 markers.","method":"rAAV-PHP.B delivery in mice (IV and ICV) and non-human primates (ICV); immunohistochemistry for D2R and DARPP32 co-localization; comparison of 12 MiniPromoter designs","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional validation across two species and multiple delivery routes","pmids":["39548191"],"is_preprint":false},{"year":2023,"finding":"Genistein activates ADORA2A and thereby inhibits oxidative stress and apoptosis in renal cells; ADORA2A overexpression mimics genistein's protective effect against hypoxia/reoxygenation injury, while ADORA2A knockdown attenuates genistein-induced protection.","method":"In vivo renal IR injury mouse model; NRK-52E cell H/R model; ADORA2A overexpression and knockdown (KO cells); oxidative stress and apoptosis assays","journal":"Human & experimental toxicology","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional manipulation (OE and KO) with consistent functional readouts in matched in vivo and in vitro models","pmids":["36932924"],"is_preprint":false}],"current_model":"ADORA2A is a G protein-coupled adenosine A2A receptor that constitutively activates adenylyl cyclase/cAMP signaling upon adenosine binding; it is selectively expressed on enkephalinergic D2-type medium spiny neurons in the striatum and forms heterodimers with DRD2, and its downstream signaling (via cAMP/PKA, ERK/MYC, STAT3/AKT, and PI3K/AKT cascades) regulates diverse processes including neuroendocrine lineage plasticity through proline-driven H3K27 deacetylation, blood-brain barrier integrity via endothelial tight-junction maintenance, retinal myopia progression through an AdoRA2a-Drd2 interaction, placental angiogenesis, vascular calcification via ferroptosis, and adipose lipolysis through epigenetic regulation of HSL."},"narrative":{"teleology":[{"year":1990,"claim":"Establishing ADORA2A as a functional adenosine A2 receptor answered the question of whether the orphan gene RDC8 encoded a ligand-gated GPCR capable of constitutive adenylyl cyclase activation.","evidence":"Heterologous expression in COS7, Y1, thyrocyte, and oocyte systems with radioligand binding and adenylyl cyclase assays","pmids":["2125216"],"confidence":"High","gaps":["No structural data on receptor–Gs coupling","Endogenous signaling partners not yet identified","Constitutive vs. ligand-gated activity ratio in native tissue unknown"]},{"year":1991,"claim":"Resolving which neuronal populations express ADORA2A showed it is restricted to enkephalinergic (D2-type) medium spiny neurons in the striatum, establishing the cellular context for its neuromodulatory role.","evidence":"In situ hybridization with neuronal subtype markers in rat brain","pmids":["1713612"],"confidence":"High","gaps":["Expression in non-striatal brain regions or non-neuronal cells not surveyed","Functional consequence of cell-type restriction not tested"]},{"year":1996,"claim":"Mapping the human ADORA2A gene to chromosome 22q11.2 and defining its two-exon structure provided the genomic framework for subsequent genetic association studies.","evidence":"Genomic cloning, FISH, and human-hamster hybrid cell panel PCR","pmids":["8670304"],"confidence":"High","gaps":["Regulatory elements and promoter architecture not characterized","No disease-associated variants identified at this locus"]},{"year":2013,"claim":"Demonstrating that a common ADORA2A haplotype modulates receptor expression and cAMP output linked human genetic variation to quantitative differences in adenosine signaling.","evidence":"SNP genotyping with mRNA, protein, and cAMP assays in lymphoblasts","pmids":["23535492"],"confidence":"Medium","gaps":["Causal variant within the haplotype not resolved","Relevance to brain-expressed ADORA2A not directly tested"]},{"year":2019,"claim":"Endothelial-specific Adora2a deletion revealed that ADORA2A is the receptor mediating insulin resistance-associated blood–brain barrier breakdown, tight junction degradation, and consequent hippocampal dysfunction.","evidence":"Inducible endothelial CKO mice with BBB permeability, electron microscopy, LTP, and behavioral assays; replicated by pharmacological antagonism","pmids":["30886019"],"confidence":"High","gaps":["Direct molecular target linking ADORA2A to tight junction protein turnover unidentified","Whether other adenosine receptors compensate long-term not tested"]},{"year":2020,"claim":"Identification of miR-497/miR-195 as direct negative regulators of ADORA2A, silenced by promoter methylation, established an epigenetic–post-transcriptional axis controlling cAMP/PKA-driven osteogenic differentiation.","evidence":"Luciferase reporter validation, demethylation with 5-aza-dC, miRNA overexpression/knockdown, cAMP/PKA readout","pmids":["32432317"],"confidence":"Medium","gaps":["In vivo significance of miR-497/195-ADORA2A axis in ossification not confirmed","Whether this regulatory axis operates in other cell types unknown"]},{"year":2022,"claim":"Demonstrating ADORA2A–DRD2 heterodimer formation in retinal epithelial cells and showing that JMJD3-mediated H3K27me3 demethylation transcriptionally upregulates ADORA2A in macrophages expanded the receptor's known interaction partners and upstream epigenetic control mechanisms.","evidence":"Co-IP and immunofluorescence for ADORA2A-DRD2 in RPE cells; ChIP and siRNA in LPS-treated macrophages and ALI mouse model","pmids":["35724635","36456564"],"confidence":"Medium","gaps":["Stoichiometry and structural basis of ADORA2A-DRD2 heterodimer unresolved","Whether JMJD3-mediated regulation is tissue-specific not determined"]},{"year":2023,"claim":"ADORA2A was shown to rewire proline metabolism through ERK/MYC/PYCR, promoting SIRT6/7-dependent H3K27 deacetylation that drives neuroendocrine lineage plasticity; separately, ADORA2A signaling through STAT3/AKT was established as a placental pro-angiogenic pathway and a renal cytoprotective mechanism.","evidence":"Adora2a KO GEMMs with ChIP, metabolomics, and epistasis (neuroendocrine); in vivo Matrigel/IUGR models with pSTAT3/pAKT (placenta); renal IR injury model with bidirectional ADORA2A manipulation (kidney)","pmids":["38099497","37051927","36932924"],"confidence":"High","gaps":["How proline sensing by SIRT6/7 is mechanistically coupled remains unclear","Whether STAT3/AKT and ERK/MYC branches are activated simultaneously or context-selectively is unknown"]},{"year":2024,"claim":"Retina-specific Adora2a knockout and Drd2-CKO epistasis demonstrated that ADORA2A promotes myopia through a required ADORA2A–DRD2 interaction in the retina, while brain-specific RagA overexpression placed ADORA2A downstream of mTOR signaling in depressive behavior.","evidence":"Retinal CKO and pharmacological antagonism with Drd2-CKO epistasis; RagA transgenic mice with RNA-seq, proteomics, and behavioral rescue by istradefylline","pmids":["41533917","39373701"],"confidence":"High","gaps":["Intracellular signaling cascade linking ADORA2A-DRD2 to myopia-related scleral remodeling not defined","Mechanism by which RagA/p70S6K elevates ADORA2A expression is not determined"]},{"year":2025,"claim":"Two studies extended ADORA2A's metabolic roles: one showed ADORA2A/Rap1 mediates PARP1-POLG–triggered VSMC ferroptosis and vascular calcification, and another demonstrated that CD73-derived adenosine activates ADORA2A to reduce HSL promoter methylation and drive adipose lipolysis.","evidence":"VSMC-specific Parp1 CKO with AAV9 POLG knockdown and Adora2a inhibition; Adora2a KO mice with rescue, DNA methylation, and metabolic phenotyping on HFD","pmids":["40401372","39976204"],"confidence":"Medium","gaps":["How ADORA2A signaling targets DNA methyltransferases at the HSL promoter is unresolved","Whether Rap1 is the sole downstream mediator of ADORA2A-dependent ferroptosis is untested"]},{"year":null,"claim":"The structural basis of ADORA2A–DRD2 heterodimer formation, the tissue-specific logic selecting among divergent downstream cascades (cAMP/PKA, ERK/MYC, STAT3/AKT, PI3K/AKT, Rap1), and the mechanisms by which ADORA2A signaling modifies the epigenome at specific loci remain to be determined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No atomic-resolution structure of ADORA2A-DRD2 heterodimer","No unified model for context-dependent pathway selection","Epigenetic targeting specificity (which loci, which writers/erasers) is poorly characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,12]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,5,7,8,10]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,4,14,15]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,8,10]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,11]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5,6]}],"complexes":["ADORA2A-DRD2 heterodimer"],"partners":["DRD2","SIRT6","SIRT7","STAT3","MYC","PYCR1","JMJD3","RAP1A"],"other_free_text":[]},"mechanistic_narrative":"ADORA2A is a Gs-coupled adenosine receptor that constitutively activates adenylyl cyclase to elevate intracellular cAMP upon adenosine binding, serving as a major signaling hub linking purinergic tone to neural, vascular, metabolic, and proliferative programs [PMID:2125216]. In the brain, ADORA2A is selectively expressed on enkephalinergic D2-type medium spiny neurons of the striatum and forms functional heterodimers with dopamine receptor DRD2 that modulate ERK signaling in retinal and striatal circuits [PMID:1713612, PMID:35724635, PMID:41533917]. Beyond cAMP/PKA, ADORA2A engages ERK/MYC, STAT3/AKT, and PI3K/AKT cascades to drive context-dependent outcomes including neuroendocrine lineage reprogramming through proline metabolism-driven H3K27 deacetylation, blood–brain barrier tight-junction maintenance in endothelial cells, placental angiogenesis, white adipose lipolysis via epigenetic de-repression of hormone-sensitive lipase, and vascular smooth muscle ferroptosis [PMID:38099497, PMID:30886019, PMID:37051927, PMID:39976204, PMID:40401372]. ADORA2A also suppresses macrophage apoptosis by inhibiting caspase-3 cleavage downstream of JMJD3-mediated H3K27me3 demethylation [PMID:36456564]."},"prefetch_data":{"uniprot":{"accession":"P29274","full_name":"Adenosine receptor A2a","aliases":[],"length_aa":412,"mass_kda":44.7,"function":"Receptor for adenosine (By similarity). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P29274/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADORA2A","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADORA2A","total_profiled":1310},"omim":[{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"},{"mim_id":"615073","title":"DYSTONIA 25; DYT25","url":"https://www.omim.org/entry/615073"},{"mim_id":"600446","title":"ADENOSINE A2B RECEPTOR; ADORA2B","url":"https://www.omim.org/entry/600446"},{"mim_id":"600445","title":"ADENOSINE A3 RECEPTOR; ADORA3","url":"https://www.omim.org/entry/600445"},{"mim_id":"600042","title":"MELANOCORTIN 5 RECEPTOR; MC5R","url":"https://www.omim.org/entry/600042"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":38.3},{"tissue":"brain","ntpm":108.6},{"tissue":"lymphoid tissue","ntpm":50.4}],"url":"https://www.proteinatlas.org/search/ADORA2A"},"hgnc":{"alias_symbol":["RDC8"],"prev_symbol":["ADORA2"]},"alphafold":{"accession":"P29274","domains":[{"cath_id":"1.20.1070.10","chopping":"1-312","consensus_level":"medium","plddt":93.2295,"start":1,"end":312}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P29274","model_url":"https://alphafold.ebi.ac.uk/files/AF-P29274-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P29274-F1-predicted_aligned_error_v6.png","plddt_mean":80.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADORA2A","jax_strain_url":"https://www.jax.org/strain/search?query=ADORA2A"},"sequence":{"accession":"P29274","fasta_url":"https://rest.uniprot.org/uniprotkb/P29274.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P29274/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P29274"}},"corpus_meta":[{"pmid":"1713612","id":"PMC_1713612","title":"Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.","date":"1991","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1713612","citation_count":465,"is_preprint":false},{"pmid":"2125216","id":"PMC_2125216","title":"RDC8 codes for an adenosine A2 receptor with physiological constitutive activity.","date":"1990","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2125216","citation_count":259,"is_preprint":false},{"pmid":"17329997","id":"PMC_17329997","title":"A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep.","date":"2007","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17329997","citation_count":180,"is_preprint":false},{"pmid":"20520601","id":"PMC_20520601","title":"Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.","date":"2010","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20520601","citation_count":140,"is_preprint":false},{"pmid":"21281405","id":"PMC_21281405","title":"Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.","date":"2011","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21281405","citation_count":87,"is_preprint":false},{"pmid":"30886019","id":"PMC_30886019","title":"Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30886019","citation_count":79,"is_preprint":false},{"pmid":"21950736","id":"PMC_21950736","title":"Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.","date":"2012","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21950736","citation_count":74,"is_preprint":false},{"pmid":"28941407","id":"PMC_28941407","title":"Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28941407","citation_count":61,"is_preprint":false},{"pmid":"23535492","id":"PMC_23535492","title":"ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus.","date":"2013","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23535492","citation_count":61,"is_preprint":false},{"pmid":"19565319","id":"PMC_19565319","title":"Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder.","date":"2009","source":"European child & adolescent psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19565319","citation_count":58,"is_preprint":false},{"pmid":"19591938","id":"PMC_19591938","title":"A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.","date":"2009","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/19591938","citation_count":57,"is_preprint":false},{"pmid":"22012471","id":"PMC_22012471","title":"ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22012471","citation_count":45,"is_preprint":false},{"pmid":"32823594","id":"PMC_32823594","title":"Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32823594","citation_count":42,"is_preprint":false},{"pmid":"31817803","id":"PMC_31817803","title":"The Impact of Genetic Variations in ADORA2A in the Association between Caffeine Consumption and Sleep.","date":"2019","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/31817803","citation_count":40,"is_preprint":false},{"pmid":"30511252","id":"PMC_30511252","title":"Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.","date":"2018","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/30511252","citation_count":39,"is_preprint":false},{"pmid":"28135712","id":"PMC_28135712","title":"Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.","date":"2016","source":"Neuroepidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/28135712","citation_count":37,"is_preprint":false},{"pmid":"20512606","id":"PMC_20512606","title":"Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.","date":"2010","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20512606","citation_count":37,"is_preprint":false},{"pmid":"8670304","id":"PMC_8670304","title":"Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8670304","citation_count":32,"is_preprint":false},{"pmid":"38099497","id":"PMC_38099497","title":"ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38099497","citation_count":29,"is_preprint":false},{"pmid":"22940476","id":"PMC_22940476","title":"Effects of ADORA2A gene variation and caffeine on prepulse inhibition: a multi-level risk model of anxiety.","date":"2012","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22940476","citation_count":28,"is_preprint":false},{"pmid":"27399166","id":"PMC_27399166","title":"Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.","date":"2016","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27399166","citation_count":27,"is_preprint":false},{"pmid":"25872644","id":"PMC_25872644","title":"Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?","date":"2015","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/25872644","citation_count":26,"is_preprint":false},{"pmid":"30946941","id":"PMC_30946941","title":"Synergistic effects between ADORA2A and DRD2 genes on anxiety disorders in children with ADHD.","date":"2019","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30946941","citation_count":25,"is_preprint":false},{"pmid":"31324842","id":"PMC_31324842","title":"Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine's Effect on Postprandial Glycaemia.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31324842","citation_count":25,"is_preprint":false},{"pmid":"34733789","id":"PMC_34733789","title":"ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34733789","citation_count":22,"is_preprint":false},{"pmid":"33235193","id":"PMC_33235193","title":"ADORA2A variation and adenosine A1 receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation.","date":"2020","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33235193","citation_count":19,"is_preprint":false},{"pmid":"25629231","id":"PMC_25629231","title":"The association of ADORA2A and ADORA2B polymorphisms with the risk and severity of chronic heart failure: a case-control study of a northern Chinese population.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25629231","citation_count":19,"is_preprint":false},{"pmid":"33373678","id":"PMC_33373678","title":"Coffee effectively attenuates impaired attention in ADORA2A C/C-allele carriers during chronic sleep restriction.","date":"2020","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33373678","citation_count":18,"is_preprint":false},{"pmid":"22240468","id":"PMC_22240468","title":"Differential effects of ADORA2A gene variations in pre-attentive visual sensory memory subprocesses.","date":"2012","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22240468","citation_count":17,"is_preprint":false},{"pmid":"27262510","id":"PMC_27262510","title":"ADORA2A genotype modulates interoceptive and exteroceptive processing in a fronto-insular network.","date":"2016","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27262510","citation_count":16,"is_preprint":false},{"pmid":"27038930","id":"PMC_27038930","title":"Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.","date":"2016","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/27038930","citation_count":16,"is_preprint":false},{"pmid":"37051927","id":"PMC_37051927","title":"Adenosine-ADORA2A Promotes Ang-Induced Angiogenesis in Intrauterine Growth Restriction Placenta via the Stat3/Akt Pathway.","date":"2023","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37051927","citation_count":15,"is_preprint":false},{"pmid":"33262686","id":"PMC_33262686","title":"Genetic Polymorphism of ADORA2A Is Associated With the Risk of Epilepsy and Predisposition to Neurologic Comorbidity in Chinese Southern Children.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33262686","citation_count":15,"is_preprint":false},{"pmid":"26066465","id":"PMC_26066465","title":"Categorical complexities of Plasmodium falciparum malaria in individuals is associated with genetic variations in ADORA2A and GRK5 genes.","date":"2015","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26066465","citation_count":14,"is_preprint":false},{"pmid":"31695381","id":"PMC_31695381","title":"Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population.","date":"2019","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/31695381","citation_count":13,"is_preprint":false},{"pmid":"32473369","id":"PMC_32473369","title":"Taoren-dahuang herb pair reduces eicosanoid metabolite shifts by regulating ADORA2A degradation activity in ischaemia/reperfusion injury rats.","date":"2020","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32473369","citation_count":13,"is_preprint":false},{"pmid":"37945707","id":"PMC_37945707","title":"ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37945707","citation_count":12,"is_preprint":false},{"pmid":"36456564","id":"PMC_36456564","title":"H3K27 tri-demethylase JMJD3 inhibits macrophage apoptosis by promoting ADORA2A in lipopolysaccharide-induced acute lung injury.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36456564","citation_count":12,"is_preprint":false},{"pmid":"28215251","id":"PMC_28215251","title":"The association between caffeine consumption and objective sleep variables is dependent on ADORA2A c.1083T>C genotypes.","date":"2016","source":"Sleep medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28215251","citation_count":12,"is_preprint":false},{"pmid":"33275249","id":"PMC_33275249","title":"Serum expression of EAAT2 and ADORA2A in patients with different degrees of Alzheimer's disease.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33275249","citation_count":11,"is_preprint":false},{"pmid":"36430879","id":"PMC_36430879","title":"Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 Genetic Variants in Patients with Alzheimer's Disease.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36430879","citation_count":10,"is_preprint":false},{"pmid":"40401372","id":"PMC_40401372","title":"PARylation of POLG Mediated by PARP1 Accelerates Ferroptosis-Induced Vascular Calcification via Activating Adora2a/Rap1 Signaling.","date":"2025","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40401372","citation_count":9,"is_preprint":false},{"pmid":"35034552","id":"PMC_35034552","title":"Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35034552","citation_count":8,"is_preprint":false},{"pmid":"38494098","id":"PMC_38494098","title":"Adora2A downregulation promotes caffeine neuroprotective effect against LPS-induced neuroinflammation in the hippocampus.","date":"2024","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/38494098","citation_count":8,"is_preprint":false},{"pmid":"39373701","id":"PMC_39373701","title":"Brain Specific RagA Overexpression Triggers Depressive-Like Behaviors in Mice via Activating ADORA2A Signaling Pathway.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39373701","citation_count":7,"is_preprint":false},{"pmid":"32182774","id":"PMC_32182774","title":"The SNP rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32182774","citation_count":7,"is_preprint":false},{"pmid":"37049474","id":"PMC_37049474","title":"The ADORA2A TT Genotype Is Associated with Anti-Inflammatory Effects of Caffeine in Response to Resistance Exercise and Habitual Coffee Intake.","date":"2023","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/37049474","citation_count":7,"is_preprint":false},{"pmid":"38931158","id":"PMC_38931158","title":"Effect of ADORA2A Gene Polymorphism and Acute Caffeine Supplementation on Hormonal Response to Resistance Exercise: A Double-Blind, Crossover, Placebo-Controlled Study.","date":"2024","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/38931158","citation_count":6,"is_preprint":false},{"pmid":"37401656","id":"PMC_37401656","title":"Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling.","date":"2023","source":"Advanced biology","url":"https://pubmed.ncbi.nlm.nih.gov/37401656","citation_count":6,"is_preprint":false},{"pmid":"34685481","id":"PMC_34685481","title":"Genetics and Cognitive Vulnerability to Sleep Deprivation in Healthy Subjects: Interaction of ADORA2A, TNF-α and COMT Polymorphisms.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34685481","citation_count":6,"is_preprint":false},{"pmid":"32969158","id":"PMC_32969158","title":"The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.","date":"2020","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32969158","citation_count":6,"is_preprint":false},{"pmid":"27846189","id":"PMC_27846189","title":"The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.","date":"2017","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/27846189","citation_count":6,"is_preprint":false},{"pmid":"32448869","id":"PMC_32448869","title":"Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis.","date":"2020","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/32448869","citation_count":6,"is_preprint":false},{"pmid":"32432317","id":"PMC_32432317","title":"Methylation-mediated down-regulation of microRNA-497-195 cluster confers osteogenic differentiation in ossification of the posterior longitudinal ligament of the spine via ADORA2A.","date":"2020","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32432317","citation_count":5,"is_preprint":false},{"pmid":"39976204","id":"PMC_39976204","title":"Adenosine Monophosphate Improves Lipolysis in Obese Mice by Reducing DNA Methylation via ADORA2A Activation by Ecto-5'-Nucleotidase (CD73).","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39976204","citation_count":5,"is_preprint":false},{"pmid":"37063258","id":"PMC_37063258","title":"Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37063258","citation_count":4,"is_preprint":false},{"pmid":"36833216","id":"PMC_36833216","title":"Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36833216","citation_count":4,"is_preprint":false},{"pmid":"31140226","id":"PMC_31140226","title":"ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.","date":"2019","source":"The Israel Medical Association journal : IMAJ","url":"https://pubmed.ncbi.nlm.nih.gov/31140226","citation_count":4,"is_preprint":false},{"pmid":"37560748","id":"PMC_37560748","title":"Adenosine A2A receptor gene polymorphisms (ADORA2A) are associated with maximal concentric contraction pain.","date":"2018","source":"Meta gene","url":"https://pubmed.ncbi.nlm.nih.gov/37560748","citation_count":3,"is_preprint":false},{"pmid":"36932924","id":"PMC_36932924","title":"Genistein attenuates renal ischemia-reperfusion injury via ADORA2A pathway.","date":"2023","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36932924","citation_count":3,"is_preprint":false},{"pmid":"38892324","id":"PMC_38892324","title":"Genetic Polymorphisms of P2RX7 but Not of ADORA2A Are Associated with the Severity of SARS-CoV-2 Infection.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38892324","citation_count":3,"is_preprint":false},{"pmid":"38764528","id":"PMC_38764528","title":"Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children.","date":"2023","source":"Psychiatry and clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38764528","citation_count":3,"is_preprint":false},{"pmid":"39548191","id":"PMC_39548191","title":"New MiniPromoter Ple389 (ADORA2A) drives selective expression in medium spiny neurons in mice and non-human primates.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39548191","citation_count":3,"is_preprint":false},{"pmid":"35724635","id":"PMC_35724635","title":"7-Methylxanthine Influences the Behavior of ADORA2A-DRD2 Heterodimers in Human Retinal Pigment Epithelial Cells.","date":"2022","source":"Ophthalmic research","url":"https://pubmed.ncbi.nlm.nih.gov/35724635","citation_count":3,"is_preprint":false},{"pmid":"38731962","id":"PMC_38731962","title":"Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731962","citation_count":1,"is_preprint":false},{"pmid":"35532631","id":"PMC_35532631","title":"The Influence of ADORA2A on Levodopa-Induced Dyskinesia.","date":"2022","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/35532631","citation_count":1,"is_preprint":false},{"pmid":"36014860","id":"PMC_36014860","title":"Can the Brazilian Caffeine Expectancy Questionnaires Differentiate the CYP1A2 and ADORA2A Gene Polymorphisms?-An Exploratory Study with Brazilian Athletes.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/36014860","citation_count":1,"is_preprint":false},{"pmid":"41261949","id":"PMC_41261949","title":"Caffeine exacerbates exercise-induced gut cell damage and is influenced by ADORA2A genotype but not CYP1A2 genotype: A preliminary study.","date":"2025","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/41261949","citation_count":1,"is_preprint":false},{"pmid":"33342966","id":"PMC_33342966","title":"Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.","date":"2020","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/33342966","citation_count":1,"is_preprint":false},{"pmid":"38545853","id":"PMC_38545853","title":"Epigenetics and suicide: investigating altered H3K14ac unveiled differential expression in ADORA2A, B4GALT2 and MMP14.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/38545853","citation_count":1,"is_preprint":false},{"pmid":"40751907","id":"PMC_40751907","title":"Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy.","date":"2025","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/40751907","citation_count":0,"is_preprint":false},{"pmid":"41533917","id":"PMC_41533917","title":"Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression.","date":"2026","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/41533917","citation_count":0,"is_preprint":false},{"pmid":"40932634","id":"PMC_40932634","title":"Precision Targeting in Gastric Cancer: AI-Driven Discovery of MET, ADORA2A, CDK5R1, and ADORA1.","date":"2025","source":"Assay and drug development technologies","url":"https://pubmed.ncbi.nlm.nih.gov/40932634","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.29.679179","title":"Associative memory in human cancer cells","date":"2025-09-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.29.679179","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.08.601789","title":"Elucidating Interactome Dynamics of the A2A Adenosine Receptor","date":"2024-07-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.08.601789","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.15.659794","title":"Generation of knock-in Cre and FlpO mouse lines for precise targeting of striatal projection neurons and dopaminergic neurons","date":"2025-06-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.15.659794","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.07.592914","title":"Daily Acute Intermittent Hypoxia Elicits Age & Sex-Dependent Changes in Molecules Regulating Phrenic Motor Plasticity","date":"2024-05-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.07.592914","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.03.611039","title":"Prenatal exposure to valproic acid induces sex-specific alterations in cortical and hippocampal neuronal structure and function in rats","date":"2024-09-05","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.03.611039","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43342,"output_tokens":4592,"usd":0.099453},"stage2":{"model":"claude-opus-4-6","input_tokens":8048,"output_tokens":2990,"usd":0.172485},"total_usd":0.271938,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"RDC8 (ADORA2A) encodes an adenosine A2 receptor that constitutively activates adenylyl cyclase and the cAMP cascade; expression in COS7 cells conferred adenosine A2 binding characteristics, and this constitutive activity was inhibited by adenosine deaminase and adenosine A2 receptor antagonists.\",\n      \"method\": \"Heterologous expression in Y1 adrenal cells, dog thyrocytes, Xenopus oocytes, and COS7 cells; radioligand binding assay; adenylyl cyclase activity assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted receptor activity in multiple cell systems with pharmacological validation and binding assay\",\n      \"pmids\": [\"2125216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"ADORA2A (RDC8) is selectively expressed by enkephalinergic medium spiny neurons in the striatum (caudate-putamen), but not by substance P-containing or cholinergic neurons.\",\n      \"method\": \"In situ hybridization histochemistry combined with neuronal subtype markers in rat brain\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with cellular specificity established by co-detection of multiple neuronal markers\",\n      \"pmids\": [\"1713612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The human ADORA2A gene is organized into two exons interrupted by an ~6.4 kb intron and is chromosomally localized to 22q11.2 by fluorescent in situ hybridization and PCR analysis of hybrid cell panels.\",\n      \"method\": \"Genomic cloning, sequence analysis, FISH, PCR of human-hamster hybrid cell panels\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal localization by two independent methods (FISH and hybrid cell panel PCR)\",\n      \"pmids\": [\"8670304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The ADORA2A AA diplotype (haplotype A of rs2298383/rs5751876/rs35320474/rs4822492) is associated with higher ADORA2A mRNA and protein expression and increased cAMP production in lymphoblasts in response to adenosine, linking a genetic variant to altered intracellular adenosine/cAMP signaling.\",\n      \"method\": \"SNP genotyping, mRNA expression (qPCR), protein expression (Western blot), cAMP production assay in lymphoblasts\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (mRNA, protein, functional cAMP assay) in a single study linking genotype to receptor function\",\n      \"pmids\": [\"23535492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endothelial cell-specific deletion of Adora2a protects mice from diet-induced insulin resistance-associated blood-brain barrier (BBB) breakdown, demonstrating that Adora2a signaling in vascular endothelial cells mediates tight junction erosion, vascular inflammation, and consequent deficits in hippocampal synaptic plasticity and cognition.\",\n      \"method\": \"Inducible endothelial-specific Adora2a knockout mice; BBB permeability assays (sodium fluorescein, Evans blue); transmission electron microscopy of tight junctions; acute pharmacological antagonism; hippocampal LTP recording; behavioral memory tasks\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic knockout with multiple orthogonal readouts (permeability, ultrastructure, plasticity, behavior), replicated by pharmacological antagonism\",\n      \"pmids\": [\"30886019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADORA2A activation rewires proline metabolism through an ERK/MYC/PYCR cascade; increased proline synthesis promotes SIRT6/7-mediated deacetylation of H3K27, biasing transcription toward a neuroendocrine lineage profile. Genetic ablation of Adora2a in mouse models inhibits neuroendocrine prostate and lung cancer development.\",\n      \"method\": \"Genetically engineered mouse models (Adora2a KO); pharmacological ADORA2A blockade in vivo; transcriptomic and metabolic analyses; ChIP for H3K27ac; epistasis with ERK/MYC/PYCR pathway inhibitors\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — in vivo genetic KO with mechanistic pathway dissection (ERK/MYC/PYCR/SIRT6/7/H3K27ac) using multiple orthogonal methods\",\n      \"pmids\": [\"38099497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"JMJD3-mediated H3K27me3 demethylation upregulates ADORA2A expression, which in turn inhibits caspase-3 cleavage to suppress macrophage apoptosis in LPS-induced acute lung injury; C/EBPβ also enhances ADORA2A expression downstream of H3K27me3 demethylation.\",\n      \"method\": \"Chromatin immunoprecipitation; LPS-induced ALI mouse model and RAW264.7 cell model; TUNEL staining; flow cytometry apoptosis assay; Western blot; siRNA knockdown of JMJD3 and ADORA2A\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional KD with apoptosis readout in matched in vivo and in vitro systems\",\n      \"pmids\": [\"36456564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Adenosine activates ADORA2A to promote phosphorylation of STAT3 and AKT, resulting in increased angiogenin (Ang)-dependent angiogenesis in placenta; ADORA2A expression is downregulated in IUGR placenta and adenosine supplementation improves IUGR outcomes in mice.\",\n      \"method\": \"In vitro angiogenesis assays; in vivo Matrigel plug assays; Western blot for pSTAT3 and pAKT; diet-induced IUGR mouse model; ADORA2A expression quantification\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo functional assays with signaling pathway validation (pSTAT3/pAKT) in multiple systems\",\n      \"pmids\": [\"37051927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADORA2A promotes colorectal carcinoma cell proliferation and inhibits apoptosis via the PI3K/AKT signaling pathway, modulating Bcl-2, Bax, cleaved caspase-3, and cleaved caspase-9 levels.\",\n      \"method\": \"siRNA knockdown and plasmid overexpression of ADORA2A in CRC cell lines; CCK-8, colony formation, wound healing, transwell assays; flow cytometry apoptosis; Western blot for PI3K/AKT and apoptosis proteins\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (KD and OE) with consistent signaling and phenotypic readouts\",\n      \"pmids\": [\"37945707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-497 and miR-195 directly target ADORA2A; promoter CpG island methylation silences the miR-497-195 cluster, leading to upregulation of ADORA2A which activates the cAMP/PKA signaling pathway and promotes osteogenic differentiation of posterior longitudinal ligament cells.\",\n      \"method\": \"Luciferase reporter assay (miRNA target validation); methylation analysis with demethylation reagent 5-aza-2'-deoxycytidine; overexpression and knockdown of miR-195/miR-497; cAMP/PKA pathway readout by Western blot; osteogenic factor expression\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — validated miRNA-target relationship with epigenetic mechanism and downstream signaling readout\",\n      \"pmids\": [\"32432317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PARP1-mediated PARylation of POLG triggers its ubiquitination and downregulation, causing mitochondrial dysfunction and activating Adora2a/Rap1 signaling to induce VSMC ferroptosis and vascular calcification; Adora2a inhibition attenuates this process.\",\n      \"method\": \"VSMC knockout mouse models (Parp1flox/flox Tagln Cre+); AAV9-mediated POLG knockdown; RNA-sequencing; Western blot for PARylation and Adora2a/Rap1; functional calcification and ferroptosis assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and molecular dissection of PARP1-POLG-Adora2a pathway in matched in vivo and in vitro models\",\n      \"pmids\": [\"40401372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AMP is converted to adenosine by ecto-5'-nucleotidase (CD73), and adenosine activates ADORA2A signaling to reduce DNA methylation at the hormone-sensitive lipase (HSL) promoter, thereby promoting HSL transcription and white adipose tissue lipolysis; ADORA2A knockout abolishes these metabolic benefits.\",\n      \"method\": \"ADORA2A knockout mice; ADORA2A re-expression rescue; DNA methylation analysis; HSL transcription assay; metabolic phenotyping in high-fat diet mice\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO plus rescue genetic strategy with epigenetic and transcriptional mechanistic readouts\",\n      \"pmids\": [\"39976204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ADORA2A and DRD2 form heterodimers in human retinal pigment epithelial (RPE) cells, as demonstrated by immunofluorescence colocalization and co-immunoprecipitation; the adenosine receptor antagonist 7-methylxanthine inhibits ADORA2A expression and increases DRD2 and downstream pERK1/2 signaling.\",\n      \"method\": \"Immunofluorescence; co-immunoprecipitation; siRNA knockdown of DRD2; Western blot for ERK1/2 and pERK1/2; CCK-8 and flow cytometry for cell viability\",\n      \"journal\": \"Ophthalmic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-immunoprecipitation demonstrating ADORA2A-DRD2 heterodimer with functional downstream signaling validation\",\n      \"pmids\": [\"35724635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Caffeine pretreatment reduces hippocampal Il1b expression and downregulates Adora2a expression in mice; LPS reverses caffeine-induced Adora2a downregulation. Bioinformatics identified MAPK3, ARRB2, and ADORA2B as network connectors to ADORA2A's extended signaling network.\",\n      \"method\": \"In vivo mouse model (caffeine + LPS); qPCR for Adora2a and cytokines; DNA methyltransferase expression analysis; bioinformatics network analysis\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — in vivo expression data with pharmacological perturbation but limited mechanistic dissection\",\n      \"pmids\": [\"38494098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Brain-specific RagA overexpression elevates ADORA2A expression and phospho-p70S6K in the prefrontal cortex; pharmacological inhibition of ADORA2A with istradefylline attenuates depressive-like behaviors in RagA transgenic mice, placing ADORA2A downstream of RagA/p70S6K in a depression-related signaling pathway.\",\n      \"method\": \"RagA transgenic mice; RNA-seq of prefrontal cortex; Western blot for ADORA2A and p70S6K; behavioral testing with ADORA2A antagonist; metabolomics and proteomics\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with transcriptomic/proteomic profiling plus pharmacological rescue establishing pathway placement\",\n      \"pmids\": [\"39373701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Retina-specific AdoRA2a knockout (AdoRA2a-CKO) mice show attenuated form deprivation myopia progression; AdoRA2a and Drd2 are colocalized in the retina, and the selective AdoRA2a antagonist KW6002 fails to inhibit myopia in Drd2-CKO mice, demonstrating that retinal AdoRA2a promotes myopia progression through an AdoRA2a-Drd2 interaction mechanism.\",\n      \"method\": \"Retina-specific CKO mice; pharmacological AdoRA2a antagonism (KW6002); Drd2-CKO epistasis experiment; immunolocalization of AdoRA2a and Drd2; refractive error measurement\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO plus genetic epistasis (Drd2 KO) establishing pathway placement with pharmacological corroboration\",\n      \"pmids\": [\"41533917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A MiniPromoter derived from ADORA2A regulatory regions (Ple389) drives selective gene expression in D2-receptor-positive medium spiny neurons in the striatum of mice and non-human primates when delivered via rAAV, validated by co-localization with dopamine D2 receptor and DARPP32 markers.\",\n      \"method\": \"rAAV-PHP.B delivery in mice (IV and ICV) and non-human primates (ICV); immunohistochemistry for D2R and DARPP32 co-localization; comparison of 12 MiniPromoter designs\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional validation across two species and multiple delivery routes\",\n      \"pmids\": [\"39548191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Genistein activates ADORA2A and thereby inhibits oxidative stress and apoptosis in renal cells; ADORA2A overexpression mimics genistein's protective effect against hypoxia/reoxygenation injury, while ADORA2A knockdown attenuates genistein-induced protection.\",\n      \"method\": \"In vivo renal IR injury mouse model; NRK-52E cell H/R model; ADORA2A overexpression and knockdown (KO cells); oxidative stress and apoptosis assays\",\n      \"journal\": \"Human & experimental toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (OE and KO) with consistent functional readouts in matched in vivo and in vitro models\",\n      \"pmids\": [\"36932924\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADORA2A is a G protein-coupled adenosine A2A receptor that constitutively activates adenylyl cyclase/cAMP signaling upon adenosine binding; it is selectively expressed on enkephalinergic D2-type medium spiny neurons in the striatum and forms heterodimers with DRD2, and its downstream signaling (via cAMP/PKA, ERK/MYC, STAT3/AKT, and PI3K/AKT cascades) regulates diverse processes including neuroendocrine lineage plasticity through proline-driven H3K27 deacetylation, blood-brain barrier integrity via endothelial tight-junction maintenance, retinal myopia progression through an AdoRA2a-Drd2 interaction, placental angiogenesis, vascular calcification via ferroptosis, and adipose lipolysis through epigenetic regulation of HSL.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ADORA2A is a Gs-coupled adenosine receptor that constitutively activates adenylyl cyclase to elevate intracellular cAMP upon adenosine binding, serving as a major signaling hub linking purinergic tone to neural, vascular, metabolic, and proliferative programs [PMID:2125216]. In the brain, ADORA2A is selectively expressed on enkephalinergic D2-type medium spiny neurons of the striatum and forms functional heterodimers with dopamine receptor DRD2 that modulate ERK signaling in retinal and striatal circuits [PMID:1713612, PMID:35724635, PMID:41533917]. Beyond cAMP/PKA, ADORA2A engages ERK/MYC, STAT3/AKT, and PI3K/AKT cascades to drive context-dependent outcomes including neuroendocrine lineage reprogramming through proline metabolism-driven H3K27 deacetylation, blood–brain barrier tight-junction maintenance in endothelial cells, placental angiogenesis, white adipose lipolysis via epigenetic de-repression of hormone-sensitive lipase, and vascular smooth muscle ferroptosis [PMID:38099497, PMID:30886019, PMID:37051927, PMID:39976204, PMID:40401372]. ADORA2A also suppresses macrophage apoptosis by inhibiting caspase-3 cleavage downstream of JMJD3-mediated H3K27me3 demethylation [PMID:36456564].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing ADORA2A as a functional adenosine A2 receptor answered the question of whether the orphan gene RDC8 encoded a ligand-gated GPCR capable of constitutive adenylyl cyclase activation.\",\n      \"evidence\": \"Heterologous expression in COS7, Y1, thyrocyte, and oocyte systems with radioligand binding and adenylyl cyclase assays\",\n      \"pmids\": [\"2125216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural data on receptor–Gs coupling\", \"Endogenous signaling partners not yet identified\", \"Constitutive vs. ligand-gated activity ratio in native tissue unknown\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Resolving which neuronal populations express ADORA2A showed it is restricted to enkephalinergic (D2-type) medium spiny neurons in the striatum, establishing the cellular context for its neuromodulatory role.\",\n      \"evidence\": \"In situ hybridization with neuronal subtype markers in rat brain\",\n      \"pmids\": [\"1713612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Expression in non-striatal brain regions or non-neuronal cells not surveyed\", \"Functional consequence of cell-type restriction not tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapping the human ADORA2A gene to chromosome 22q11.2 and defining its two-exon structure provided the genomic framework for subsequent genetic association studies.\",\n      \"evidence\": \"Genomic cloning, FISH, and human-hamster hybrid cell panel PCR\",\n      \"pmids\": [\"8670304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulatory elements and promoter architecture not characterized\", \"No disease-associated variants identified at this locus\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that a common ADORA2A haplotype modulates receptor expression and cAMP output linked human genetic variation to quantitative differences in adenosine signaling.\",\n      \"evidence\": \"SNP genotyping with mRNA, protein, and cAMP assays in lymphoblasts\",\n      \"pmids\": [\"23535492\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal variant within the haplotype not resolved\", \"Relevance to brain-expressed ADORA2A not directly tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Endothelial-specific Adora2a deletion revealed that ADORA2A is the receptor mediating insulin resistance-associated blood–brain barrier breakdown, tight junction degradation, and consequent hippocampal dysfunction.\",\n      \"evidence\": \"Inducible endothelial CKO mice with BBB permeability, electron microscopy, LTP, and behavioral assays; replicated by pharmacological antagonism\",\n      \"pmids\": [\"30886019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target linking ADORA2A to tight junction protein turnover unidentified\", \"Whether other adenosine receptors compensate long-term not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of miR-497/miR-195 as direct negative regulators of ADORA2A, silenced by promoter methylation, established an epigenetic–post-transcriptional axis controlling cAMP/PKA-driven osteogenic differentiation.\",\n      \"evidence\": \"Luciferase reporter validation, demethylation with 5-aza-dC, miRNA overexpression/knockdown, cAMP/PKA readout\",\n      \"pmids\": [\"32432317\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of miR-497/195-ADORA2A axis in ossification not confirmed\", \"Whether this regulatory axis operates in other cell types unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating ADORA2A–DRD2 heterodimer formation in retinal epithelial cells and showing that JMJD3-mediated H3K27me3 demethylation transcriptionally upregulates ADORA2A in macrophages expanded the receptor's known interaction partners and upstream epigenetic control mechanisms.\",\n      \"evidence\": \"Co-IP and immunofluorescence for ADORA2A-DRD2 in RPE cells; ChIP and siRNA in LPS-treated macrophages and ALI mouse model\",\n      \"pmids\": [\"35724635\", \"36456564\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and structural basis of ADORA2A-DRD2 heterodimer unresolved\", \"Whether JMJD3-mediated regulation is tissue-specific not determined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"ADORA2A was shown to rewire proline metabolism through ERK/MYC/PYCR, promoting SIRT6/7-dependent H3K27 deacetylation that drives neuroendocrine lineage plasticity; separately, ADORA2A signaling through STAT3/AKT was established as a placental pro-angiogenic pathway and a renal cytoprotective mechanism.\",\n      \"evidence\": \"Adora2a KO GEMMs with ChIP, metabolomics, and epistasis (neuroendocrine); in vivo Matrigel/IUGR models with pSTAT3/pAKT (placenta); renal IR injury model with bidirectional ADORA2A manipulation (kidney)\",\n      \"pmids\": [\"38099497\", \"37051927\", \"36932924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How proline sensing by SIRT6/7 is mechanistically coupled remains unclear\", \"Whether STAT3/AKT and ERK/MYC branches are activated simultaneously or context-selectively is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Retina-specific Adora2a knockout and Drd2-CKO epistasis demonstrated that ADORA2A promotes myopia through a required ADORA2A–DRD2 interaction in the retina, while brain-specific RagA overexpression placed ADORA2A downstream of mTOR signaling in depressive behavior.\",\n      \"evidence\": \"Retinal CKO and pharmacological antagonism with Drd2-CKO epistasis; RagA transgenic mice with RNA-seq, proteomics, and behavioral rescue by istradefylline\",\n      \"pmids\": [\"41533917\", \"39373701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling cascade linking ADORA2A-DRD2 to myopia-related scleral remodeling not defined\", \"Mechanism by which RagA/p70S6K elevates ADORA2A expression is not determined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies extended ADORA2A's metabolic roles: one showed ADORA2A/Rap1 mediates PARP1-POLG–triggered VSMC ferroptosis and vascular calcification, and another demonstrated that CD73-derived adenosine activates ADORA2A to reduce HSL promoter methylation and drive adipose lipolysis.\",\n      \"evidence\": \"VSMC-specific Parp1 CKO with AAV9 POLG knockdown and Adora2a inhibition; Adora2a KO mice with rescue, DNA methylation, and metabolic phenotyping on HFD\",\n      \"pmids\": [\"40401372\", \"39976204\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How ADORA2A signaling targets DNA methyltransferases at the HSL promoter is unresolved\", \"Whether Rap1 is the sole downstream mediator of ADORA2A-dependent ferroptosis is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of ADORA2A–DRD2 heterodimer formation, the tissue-specific logic selecting among divergent downstream cascades (cAMP/PKA, ERK/MYC, STAT3/AKT, PI3K/AKT, Rap1), and the mechanisms by which ADORA2A signaling modifies the epigenome at specific loci remain to be determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No atomic-resolution structure of ADORA2A-DRD2 heterodimer\", \"No unified model for context-dependent pathway selection\", \"Epigenetic targeting specificity (which loci, which writers/erasers) is poorly characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 5, 7, 8, 10]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 4, 14, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 8, 10]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 11]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"complexes\": [\n      \"ADORA2A-DRD2 heterodimer\"\n    ],\n    \"partners\": [\n      \"DRD2\",\n      \"SIRT6\",\n      \"SIRT7\",\n      \"STAT3\",\n      \"MYC\",\n      \"PYCR1\",\n      \"JMJD3\",\n      \"RAP1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}